Bartek Bednarz | Ipsen Leadership
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership
  4. Bartek Bednarz

Bartek Bednarz

Back
Bartek Bednarz

Bartek Bednarz

  • Executive Vice President,
  • Head of Global Product and Portfolio Strategy
  • Follow in LinkedIn

Bartek Bednarz, DDS joined Ipsen in 2017.

Bartek currently serves as Executive Vice President, Head of Global Product and Portfolio Strategy at Ipsen, which covers Global Franchises, Global Value and Access and Global Strategic Business Excellence.

Before assuming his current role, Bartek successfully led Ipsen’s oncology franchise. Prior to that, he held global leadership roles at AstraZeneca and Novartis. At AstraZeneca, where Bartek spent seven years, he started as Country President and later led new launches in oncology as well as Oncology Commercial Operations at a global level while based in Cambridge (UK). At Novartis, Bartek held various commercial leadership roles at local, regional and international levels around the world, including Poland, Spain, Switzerland and Canada. He has worked across multiple therapeutic areas and is very passionate about Ipsen’s focus in oncology, rare disease and neuroscience.

Bartek Bednarz holds a Doctor of Dental Medicine, and he obtained his diploma with honors at the Medical University of Pomerania in Poland.

IPN price

€102.60

 €-1.10 (-1.06%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue